157 related articles for article (PubMed ID: 10854807)
1. Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation.
Egerer G; Goldschmidt H; Salwender H; Hegenbart U; Ehrhard I; Haas R; Ho AD
Int J Antimicrob Agents; 2000 Jul; 15(2):119-23. PubMed ID: 10854807
[TBL] [Abstract][Full Text] [Related]
2. Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantation.
Egerer G; Goldschmidt H; Hensel M; Harter C; Schneeweiss A; Ehrhard I; Bastert G; Ho AD
Bone Marrow Transplant; 2002 Oct; 30(7):427-31. PubMed ID: 12368954
[TBL] [Abstract][Full Text] [Related]
3. Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell support.
Egerer G; Goldschmidt H; Streich N; Ehrhard I; Sonntag HG; Haas R
Support Care Cancer; 1999 Sep; 7(5):336-42. PubMed ID: 10483819
[TBL] [Abstract][Full Text] [Related]
4. Low-dose continuous-infusion ceftazidime monotherapy in low-risk febrile neutropenic patients.
Marshall E; Smith DB; O'Reilly SM; Murray A; Kelly V; Clark PI
Support Care Cancer; 2000 May; 8(3):198-202. PubMed ID: 10789960
[TBL] [Abstract][Full Text] [Related]
5. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
Mullen CA; Petropoulos D; Roberts WM; Rytting M; Zipf T; Chan KW; Culbert SJ; Danielson M; Jeha SS; Kuttesch JF; Rolston KV
Cancer; 1999 Jul; 86(1):126-34. PubMed ID: 10391572
[TBL] [Abstract][Full Text] [Related]
6. Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem.
Freifeld AG; Walsh T; Marshall D; Gress J; Steinberg SM; Hathorn J; Rubin M; Jarosinski P; Gill V; Young RC
J Clin Oncol; 1995 Jan; 13(1):165-76. PubMed ID: 7799016
[TBL] [Abstract][Full Text] [Related]
7. Empiric antimicrobial therapy of febrile neutropenic patients undergoing haematopoietic stem cell transplantation.
Antabli BA; Bross P; Siegel RS; Small CD; Tabbara IA
Int J Antimicrob Agents; 1999 Oct; 13(2):127-30. PubMed ID: 10595571
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.
Ramphal R; Gucalp R; Rotstein C; Cimino M; Oblon D
Am J Med; 1996 Jun; 100(6A):83S-89S. PubMed ID: 8678102
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
Kebudi R; Görgün O; Ayan I; Gürler N; Akici F; Töreci K
Med Pediatr Oncol; 2001 Apr; 36(4):434-41. PubMed ID: 11260566
[TBL] [Abstract][Full Text] [Related]
10. Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial.
Harter C; Schulze B; Goldschmidt H; Benner A; Geiss HK; Hoppe-Tichy T; Ho AD; Egerer G
Bone Marrow Transplant; 2006 Feb; 37(4):373-9. PubMed ID: 16400334
[TBL] [Abstract][Full Text] [Related]
11. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
Hess U; Böhme C; Rey K; Senn HJ
Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
[TBL] [Abstract][Full Text] [Related]
12. Randomised comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients.
Aparicio J; Oltra A; Llorca C; Montalar J; Herranz C; Gómez-Codina J; Pastor M; Munárriz B
Eur J Cancer; 1996 Sep; 32A(10):1739-43. PubMed ID: 8983283
[TBL] [Abstract][Full Text] [Related]
13. [Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
Pérez C; Sirham M; Labarca J; Grebe G; Lira P; Oliva J; Duhalde M; Ocqueteau M; Acuña G
Rev Med Chil; 1995 Mar; 123(3):312-20. PubMed ID: 8525170
[TBL] [Abstract][Full Text] [Related]
14. Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer.
Chuang YY; Hung IJ; Yang CP; Jaing TH; Lin TY; Huang YC
Pediatr Infect Dis J; 2002 Mar; 21(3):203-9. PubMed ID: 12005083
[TBL] [Abstract][Full Text] [Related]
15. Trimethoprim-sulfamethoxazole plus amikacin versus ceftazidime monotherapy as empirical treatment in patients with neutropenia and fever.
Engervall P; Günther G; Ljungman P; Lönnqvist B; Hast R; Stiernstedt G; Kalin M; Ringertz S; Bjökholm M
Scand J Infect Dis; 1996; 28(3):297-303. PubMed ID: 8863366
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients.
Escalante CP; Weiser MA; Manzullo E; Benjamin R; Rivera E; Lam T; Ho V; Valdres R; Lee EL; Badrina N; Fernandez S; DeJesus Y; Rolston K
Support Care Cancer; 2004 Sep; 12(9):657-62. PubMed ID: 15185134
[TBL] [Abstract][Full Text] [Related]
17. An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients. German Multicentre Study Group.
Höffken G; Pasold R; Pflüger KH; Finke J; Fauser AA; Szelenyi H; Wagner J
J Antimicrob Chemother; 1999 Sep; 44(3):367-76. PubMed ID: 10511404
[TBL] [Abstract][Full Text] [Related]
18. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
Hidalgo M; Hornedo J; Lumbreras C; Trigo JM; Colomer R; Perea S; Gómez C; Ruiz A; García-Carbonero R; Cortés-Funes H
Cancer; 1999 Jan; 85(1):213-9. PubMed ID: 9921995
[TBL] [Abstract][Full Text] [Related]
19. A prospective, randomized study comparing cefozopran with piperacillin-tazobactam plus ceftazidime as empirical therapy for febrile neutropenia in children with hematological disorders.
Sato T; Kobayashi R; Yasuda K; Kaneda M; Iguchi A; Kobayashi K
Pediatr Blood Cancer; 2008 Dec; 51(6):774-7. PubMed ID: 18661495
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.
Mustafa MM; Carlson L; Tkaczewski I; McCracken GH; Buchanan GR
Pediatr Infect Dis J; 2001 Mar; 20(3):362-9. PubMed ID: 11303851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
